Document Detail

In vitro metabolism and inductive or inhibitive effect of DL111 on rat cytochrome P4501A enzyme.
MedLine Citation:
PMID:  15013813     Owner:  NLM     Status:  MEDLINE    
In vitro metabolism and the inductive or inhibitive effect of DL111, a non-hormonal early pregnancy-terminating agent, toward cytochrome P450 (CYP) enzymes in rat liver microsomes were studied. In vitro metabolism of DL111 was performed in different rat liver microsomes (pretreated with phenobarbital (PB), dexamethasone (Dex), beta-naphthoflavone (BNF), DL111, respectively) and the catalytic abilities of these microsomes for DL111 were compared with control group. DL111 was well metabolized in microsomes pretreated with beta-naphthoflavone and itself. The K(m) and V(max) was 41.76 +/- 3.26 microM and 15.34 +/- 1.03 nM min(-1) mg(-1) protein for beta-naphthoflavone group, 48.17 +/- 6.06 microM and 17.54 +/- 1.79 nM min(-1)mg(-1) protein for DL111 group, 77.81 +/- 4.73 microM and 3.087 +/- 0.202 nM min(-1)mg(-1) protein for control group, respectively. The rats were pretreated intraperitoneally with the same daily dose of DL111 for different days. The DL111-pretreated microsomal enzymatic activities were evaluated by measuring the metabolic abilities for specific substrates of various enzymes. The results showed that DL111 had the same inductive function as beta-naphthoflavone (the specific inducer of CYP1A) toward rat liver microsomes. The inhibitive effect of DL111 on CYP1A was investigated by coincubating DL111 with the specific substrates of CYP1A-ethoxyresorufin or phenacetin in the microsome induced by beta-naphthoflavone, and the inhibitive level was compared with fluvoxamine (Flu), the specific inhibitor of CYP1A. DL111 inhibited significantly the metabolism of phenacetin and ethoxyresorufin with the inhibition constant (K(i)) 6.836 +/- 0.10 and 1.222 +/- 0.230 microM, respectively and its inhibition potential on CYP1A was higher than fluvoxamine.
Yun-Zhen Hu; Tong-Wei Yao
Related Documents :
4024103 - The embryotoxicity of adriamycin in rat embryos in vitro.
11514173 - Novel 4-piperidinopyridine inhibitors of oxidosqualene cyclase-lanosterol synthase deri...
3883213 - Effects of progesterone on the pituitary responsiveness to, and priming effect of lutei...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chemico-biological interactions     Volume:  147     ISSN:  0009-2797     ISO Abbreviation:  Chem. Biol. Interact.     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-03-11     Completed Date:  2004-04-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0227276     Medline TA:  Chem Biol Interact     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  109-17     Citation Subset:  IM    
Department of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, 353 Yan'an Road, Hangzhou, Zhejiang 310031, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortifacient Agents, Nonsteroidal / metabolism,  pharmacology*
Chromatography, High Pressure Liquid
Cytochrome P-450 CYP1A1 / biosynthesis*
Dexamethasone / pharmacology
Dose-Response Relationship, Drug
Drug Therapy, Combination
Enzyme Induction / drug effects
Enzyme Inhibitors / metabolism,  pharmacology*
Microsomes, Liver / drug effects,  enzymology
Phenobarbital / pharmacology
Rats, Sprague-Dawley
Triazoles / metabolism,  pharmacology*
beta-Naphthoflavone / pharmacology
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 0/Enzyme Inhibitors; 0/Triazoles; 50-02-2/Dexamethasone; 50-06-6/Phenobarbital; 6051-87-2/beta-Naphthoflavone; 69095-83-6/3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole; EC P-450 CYP1A1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Positive autoregulation of the Myocyte enhancer factor-2 myogenic control gene during somatic muscle...
Next Document:  Polypeptide from Chlamys farreri protects HaCaT cells from UVB-induced apoptosis.